AlloSure® is the first and only dd-cfDNA test developed specifically for transplant care.
AlloSure® is the first and only dd-cfDNA test developed specifically for transplant care.
HeartCare® provides a comprehensive assessment of graft health by combining AlloMap® Heart gene expression profiling with AlloSure Heart dd-cfDNA.
AlloSure® Lung brings the technology of the first and only dd-cfDNA test developed specifically for transplant care to address the high unmet need of lung transplant recipients.